My Treatment Approach: Improving Chronic Lymphocytic Leukemia Management and Treatment Outcomes - Episode 4

Implications of Real-World Data in the 1L Treatment of High-Risk CLL

, ,

Catherine C. Coombs, MD, discusses the value of real-world data in informing the treatment of patients with chronic lymphocytic leukemia.

EP. 1: Patient with Newly Diagnosed CLL with High-Risk Features
EP. 2: Expert Perspectives on 1L Treatment Approaches in Newly Diagnosed CLL
EP. 3: Navigating Continuous BTKi Therapy for CLL in the 1L Setting
Now Viewing
EP. 4: Implications of Real-World Data in the 1L Treatment of High-Risk CLL

Video content above is prompted by the following question(s):

  • Please outline your general treatment strategy for patients with high-risk CLL. How do recently presented real-world data influence your treatment approach?